Skip to content
Back to Guavy Wire
Stocks

Amgen Sued Over Data Breach Exposing Customer Health Info

Instruments
AMGN
Share

A class action lawsuit has been filed against Amgen, a prescription drug giant, over a data breach in July. The suit claims that the company failed to protect its customers' personal information from cybercriminals.

According to the complaint, a group of hackers accessed Amgen's computer systems and stole data including names, addresses, billing information, health conditions, diagnoses, and other sensitive health-related information.

The lead plaintiff, Heidi Humphreys, is seeking damages, restitution, and disgorgement on behalf of herself and potentially over 100 other customers whose data was compromised in the breach.

Humphreys claims that Amgen's failure to implement reasonable cybersecurity measures was foreseeable and likely to result in a data breach. She also notes that stolen identity credentials can be sold on the dark web for as little as $40, with bank details selling for up to $200.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc